These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

867 related articles for article (PubMed ID: 30756423)

  • 1. Atopic dermatitis disease registry in Japanese adult patients with moderate to severe atopic dermatitis (ADDRESS-J): Baseline characteristics, treatment history and disease burden.
    Katoh N; Saeki H; Kataoka Y; Etoh T; Teramukai S; Takagi H; Tajima Y; Ardeleanu M; Rizova E; Arima K;
    J Dermatol; 2019 Apr; 46(4):290-300. PubMed ID: 30756423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of standard treatments for managing adult Japanese patients with inadequately controlled moderate-to-severe atopic dermatitis: Two-year data from the ADDRESS-J disease registry.
    Katoh N; Saeki H; Kataoka Y; Etoh T; Teramukai S; Takagi H; Fujita H; Ardeleanu M; Rizova E; Arima K;
    J Dermatol; 2022 Sep; 49(9):903-911. PubMed ID: 35715964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease burden and patient characteristics associated with systemic therapy utilization among adults with atopic dermatitis: data from CorEvitas Atopic Dermatitis Registry.
    Silverberg JI; Gold LS; Desai S; Golant A; DiRuggiero D; Fenske DC; Li A; Dawson Z; Muñoz Maldonado Y; Ho K; Callahan K; Simpson EL
    J Dermatolog Treat; 2024 Dec; 35(1):2396382. PubMed ID: 39322226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease burden and treatment history among adults with atopic dermatitis receiving systemic therapy: baseline characteristics of participants on the EUROSTAD prospective observational study.
    Bruin-Weller M; Pink AE; Patrizi A; Gimenez-Arnau AM; Agner T; Roquet-Gravy PP; Ferrucci SM; Arenberger P; Svensson A; Schuttelaar MLA; Nosbaum A; Jayawardena S; Rizova E; Ardeleanu M; Eckert L; Ozturk ZE
    J Dermatolog Treat; 2021 Mar; 32(2):164-173. PubMed ID: 33461356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AtopyReg
    Stingeni L; Chiricozzi A; Calzavara-Pinton P; Napolitano M; Peris K; Schena D; Patruno C; Rossi M; Foti C; Fargnoli MC; Corazza M; Ferrucci SM; Pigatto PD; Romanelli M; Fabbrocini G; Girolomoni G; Passante M; Romita P; Esposito M; Schettini N; Marzano AV; Tonini G; Marietti R; Casciola G; Argenziano G; Hansel K;
    Am J Clin Dermatol; 2024 Jan; 25(1):149-160. PubMed ID: 37725229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation Analysis of Clinician- and Patient-Reported Outcomes Among Japanese Adults with Atopic Dermatitis.
    Saeki H; Kataoka Y; Etoh T; Katoh N; Teramukai S; Tajima Y; Fujita H; Ardeleanu M; Arima K
    Dermatol Ther (Heidelb); 2024 Feb; 14(2):533-543. PubMed ID: 38326699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical Trial.
    Paller AS; Bansal A; Simpson EL; Boguniewicz M; Blauvelt A; Siegfried EC; Guttman-Yassky E; Hultsch T; Chen Z; Mina-Osorio P; Lu Y; Rossi AB; He X; Kamal M; Graham NMH; Pirozzi G; Ruddy M; Eckert L; Gadkari A
    Am J Clin Dermatol; 2020 Feb; 21(1):119-131. PubMed ID: 31823222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upadacitinib plus topical corticosteroids in atopic dermatitis: Week 52 AD Up study results.
    Silverberg JI; de Bruin-Weller M; Bieber T; Soong W; Kabashima K; Costanzo A; Rosmarin D; Lynde C; Liu J; Gamelli A; Zeng J; Ladizinski B; Chu AD; Reich K
    J Allergy Clin Immunol; 2022 Mar; 149(3):977-987.e14. PubMed ID: 34403658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
    Blauvelt A; de Bruin-Weller M; Gooderham M; Cather JC; Weisman J; Pariser D; Simpson EL; Papp KA; Hong HC; Rubel D; Foley P; Prens E; Griffiths CEM; Etoh T; Pinto PH; Pujol RM; Szepietowski JC; Ettler K; Kemény L; Zhu X; Akinlade B; Hultsch T; Mastey V; Gadkari A; Eckert L; Amin N; Graham NMH; Pirozzi G; Stahl N; Yancopoulos GD; Shumel B
    Lancet; 2017 Jun; 389(10086):2287-2303. PubMed ID: 28478972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attentiveness and mental health in adolescents with moderate-to-severe atopic dermatitis without ADHD.
    Paller AS; Gonzalez ME; Barnum S; Jaeger J; Shao L; Ozturk ZE; Korotzer A
    Arch Dermatol Res; 2024 Jul; 316(8):497. PubMed ID: 39080094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.
    Beck LA; Thaçi D; Hamilton JD; Graham NM; Bieber T; Rocklin R; Ming JE; Ren H; Kao R; Simpson E; Ardeleanu M; Weinstein SP; Pirozzi G; Guttman-Yassky E; Suárez-Fariñas M; Hager MD; Stahl N; Yancopoulos GD; Radin AR
    N Engl J Med; 2014 Jul; 371(2):130-9. PubMed ID: 25006719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical phenotyping of atopic dermatitis using combined itch and lesional severity: A prospective observational study.
    Chovatiya R; Lei D; Ahmed A; Chavda R; Gabriel S; Silverberg JI
    Ann Allergy Asthma Immunol; 2021 Jul; 127(1):83-90.e2. PubMed ID: 33819616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease burden among patients with atopic dermatitis treated with systemic therapy for 4-12 months: results from the CorEvitas Atopic Dermatitis Registry.
    Silverberg JI; Pierce E; Feely M; Atwater AR; Schrader A; Jones EA; Dave SS; Simpson EL
    J Dermatolog Treat; 2023 Dec; 34(1):2246601. PubMed ID: 37691405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe and ChRonic Atopic dermatitis Treatment CoHort (SCRATCH): A Danish Real-world Evidence Atopic Dermatitis Treatment Registry.
    Larsen HH; Vittrup I; Ruge IF; Elberling J; Skov L; Ibler K; Jemec GB; Mørtz CG; Bach RO; Bindslev-Jensen C; Dalager M; Agner T; Deleuran M; Vestergaard C; Thyssen JP
    Acta Derm Venereol; 2022 Aug; 102():adv00760. PubMed ID: 35670330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two phase III trials.
    Silverberg JI; Simpson EL; Ardeleanu M; Thaçi D; Barbarot S; Bagel J; Chen Z; Eckert L; Chao J; Korotzer A; Rizova E; Rossi AB; Lu Y; Graham NMH; Hultsch T; Pirozzi G; Akinlade B
    Br J Dermatol; 2019 Jul; 181(1):80-87. PubMed ID: 30791102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase 1 studies to assess the safety, tolerability and pharmacokinetics of JTE-052 (a novel Janus kinase inhibitor) ointment in Japanese healthy volunteers and patients with atopic dermatitis.
    Nakagawa H; Nemoto O; Yamada H; Nagata T; Ninomiya N
    J Dermatol; 2018 Jun; 45(6):701-709. PubMed ID: 29665062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus.
    Kabashima K; Matsumura T; Komazaki H; Kawashima M;
    N Engl J Med; 2020 Jul; 383(2):141-150. PubMed ID: 32640132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults.
    Paller AS; Tom WL; Lebwohl MG; Blumenthal RL; Boguniewicz M; Call RS; Eichenfield LF; Forsha DW; Rees WC; Simpson EL; Spellman MC; Stein Gold LF; Zaenglein AL; Hughes MH; Zane LT; Hebert AA
    J Am Acad Dermatol; 2016 Sep; 75(3):494-503.e6. PubMed ID: 27417017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline Demographics, Comorbidities, Treatment Patterns and Burden of Atopic Dermatitis in Adults and Adolescents from the GLOBOSTAD Long-Term Observational Study.
    Calzavara-Pinton P; Čelakovská J; Lapeere H; Holzer G; Al-Ahmad M; Chu CY; Ferrucci SM; Kataoka Y; Rossi M; Fomina DS; Chung WH; Tzellos T; Fougerousse AC; Wu J; Ardeleanu M; Ozturk ZE
    Adv Ther; 2023 Dec; 40(12):5366-5382. PubMed ID: 37801232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wet-wrap therapy with halometasone cream for severe adult atopic dermatitis.
    Xu W; Li Y; Chen Z; Liu T; Wang S; Li L
    Postgrad Med; 2018 Jun; 130(5):470-476. PubMed ID: 29768078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.